Healthcare

CSL Decides Against CEO Salary Raise While Board Members Take A Healthy Pay Rise

CSL Limited (ASX: CSL) has decided not to give any raise to CEO Paul Perreault in his base pay this year. The remuneration committee...

Lifespot Health pressed the pause button on ASX

Lifespot Health Limited’s stock went into trading halt today. In an announcement to ASX, health care group Lifespot Health requested ASX to grant trading...
primary healthcare

Primary Health Care Announces the Release of Determination by the Fair Work Commission

Leading healthcare company in Australia, Primary Health Care Limited (ASX: PRY) announced that Fair Work Commission has released a decision and drafted workplace determination...
CPH

Creso seeks shareholders’ approval for Columbian Kunna acquisition

Cannabis company Creso Pharma Limited ( ASX: CPH ) announced the notice of general meeting which is to be held on 16th October 2018,...

Telix Pharmaceuticals completes the acquisition of France-based biotechnology company Atlab Pharma

Telix Pharmaceuticals (ASX: TLX) completes the acquisition of French biotechnology company Atlab Pharma for USD$10 million in shares. Biopharmaceutical company Telix address unmet medical...
nanosonic healthcare stocks

One Healthcare stock on the watchlist – Nanosonic Limited

Nanosonics’ stock continues to slide lower as the company’s revenue has squeezed in the financial year ended 30 June 2018. However, the FY18 results...
Imagion Biosystems

Imagion Biosystems moves closer to first-in-human clinical study

Healthcare company Imagion Biosystems has announced the success in achieving a key milestone of optimizing nanoparticle formulation in a drive to first-in-human testing. In the...

G Medical Innovations Enters Final Phase of Commercial Approval in China

G Medical Innovations (ASX: GMV) updated that regulatory audits for its facility in China are scheduled to be conducted towards the end of this...

Federal funding cuts wiped out Regis’ earnings

Funding cuts by Federal government took away Regis Healthcare’s (ASX: REG) earnings as the ASX listed aged care services provider reported lower EBITDA of...
starpharma holdings

Starpharma’s DEP irinotecan showed significant anti-cancer efficacy with complete tumour regression

Starpharma Holdings Limited’s (ASX: SPL) share price surged 3.387% to $1.282 after announcing that its proprietary DEP irinotecan development candidate showed complete tumour regression...

Recent Posts